Search for " " - 2/491

Results for “ ”

Entry	Author	Date	Location
Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto	Sarah de Crescenzo	01/07/20	San Diego
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic	Frank Vinluan	01/07/20	Boston
BioIntervene Raises $30M to Move Nerve Pain Drug Into the Clinic	Sarah de Crescenzo	01/07/20	San Diego
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex	Frank Vinluan	01/06/20	New York
China’s CF PharmTech Raises $90M to Advance Respiratory Drug Development	Melissa Fassbender	01/06/20	National
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More	Frank Vinluan	01/03/20	National
After Antitrust Challenges, Illumina and PacBio Throw in Towel on Merger	Sarah de Crescenzo	01/03/20	San Diego
No More Fish or Fruit: Intrexon Turns SynBio Focus to Human Health	Frank Vinluan	01/02/20	National
Rexgenero CEO Talks Importance of “Dialogue” in Cell Therapy Conversations	Sarah de Crescenzo	01/02/20	National
Wave’s Huntington’s Drug Disappoints in Clinical Trial, Stock Sinks	Melissa Fassbender	01/02/20	Boulder/Denver
Investors Go With Gut Ahead of Microbiome Therapy Boom, Says Seventure	Dan Stanton	01/01/20	National
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines	Sarah de Crescenzo	12/24/19	National
Evotec CEO Discusses Ways to Make Drug R&D Faster and Better	Melissa Fassbender	12/24/19	National
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal	Sarah de Crescenzo	12/23/19	Boston
Healthcare AI Tech is Here, Now We Must Learn to Manage the Data	Dan Stanton	12/23/19	National
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More	Sarah de Crescenzo	12/20/19	National
Biogen Strikes Alzheimer’s Deal, Paying $45M for Ionis Tau Drug Rights	Sarah de Crescenzo	12/19/19	San Diego
Takeda Pays Turnstone $120M to Start Alliance on Viral Cancer Therapies	Frank Vinluan	12/19/19	New York
Ring Therapeutics Launches to Expand Gene Therapy Viral Vector Options	Sarah de Crescenzo	12/19/19	Boston
ArcherDX Raises $55M to Help Physicians Pick Best Cancer Therapies	Melissa Fassbender	12/18/19	Boulder/Denver
FTC Challenges PacBio Acquisition, Says Illumina is a “Monopolist”	Sarah de Crescenzo	12/18/19	San Diego
Zafgen’s Path Forward Is Reverse Merger With Chondrial Therapeutics	Frank Vinluan	12/18/19	Boston
Orbiting Organoids: Research in Space to Unveil New Neurodegeneration Insight	Melissa Fassbender	12/18/19	National
ALS Fund Talks Investments and Strategy as it Kicks Off $100M Campaign	Melissa Fassbender	12/17/19	National
Triplet Therapeutics Unveils $59M to Try Hairpin Fix for Huntington’s	Frank Vinluan	12/17/19	Boston
Organovo’s Demise Offers Path for Tarveda to Join the Public Markets	Sarah de Crescenzo	12/16/19	San Diego
Wave Stock Crashes After Decision to Halt Duchenne Drug Studies	Melissa Fassbender	12/16/19	Boston
Cell Reprogramming Startup Bit Bio Inks Pact With Charles River	Melissa Fassbender	12/16/19	Boston
Axsome’s Depression Drug Meets Phase 3 Goals, FDA Filing Planned	Frank Vinluan	12/16/19	New York
Building a Better 3D Bioprinter: GE Healthcare and ASLS Combine Tech	Melissa Fassbender	12/16/19	Boston
Page 2 of 383	« previous page · next page »